Mail

Singapore markets open in 5 hours 17 minutes

Straits Times Index
3,439.88
+24.37(+0.71%)
S&P 500
5,537.02
+28.01(+0.51%)
Dow
39,308.00
-23.90(-0.06%)
Nasdaq
18,188.30
+159.54(+0.88%)
Bitcoin USD
58,524.64
-1,352.45(-2.26%)
CMC Crypto 200
1,217.58
-43.60(-3.46%)

Aurobindo Pharma Limited (AUROPHARMA.NS)

NSE - NSE Real-time price. Currency in INR

Add to watchlist

1,254.65

+15.85

(+1.28%)

At close: 03:30PM IST

Currency in INR

Earnings estimate	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2022)	Next year (2023)
No. of analysts	2	2	25	25
Avg. Estimate	14	14.17	55.77	62.29
Low estimate	13.3	13.94	47.7	49.1
High estimate	14.7	14.4	63.52	69.28
Year ago EPS	N/A	N/A	N/A	55.77

Revenue estimate	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2022)	Next year (2023)
No. of analysts	3	3	26	25
Avg. Estimate	61.7B	63.62B	250.11B	271.28B
Low estimate	59.2B	62.27B	234.74B	242.8B
High estimate	64.52B	65.38B	268.4B	298.66B
Year ago sales	N/A	N/A	N/A	250.11B
Sales growth (year/est)	N/A	N/A	N/A	8.50%

Earnings history	Invalid Date	Invalid Date	Invalid Date	30/06/2021
Est. EPS	N/A	N/A	N/A	14.53
Actual EPS	N/A	N/A	N/A	13.14
Difference	N/A	N/A	N/A	-1.39
Surprise %	N/A	N/A	N/A	-9.60%

EPS trend	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2022)	Next year (2023)
Current estimate	14	14.17	55.77	62.29
7 days ago	0	0	0	0
30 days ago	0	0	0	0
60 days ago	0	0	0	0
90 days ago	0	0	0	0

EPS revisions	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2022)	Next year (2023)
Up last 7 days	N/A	N/A	1	N/A
Up last 30 days	N/A	N/A	1	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	1

Growth estimates	AUROPHARMA.NS	Industry	Sector(s)	S&P 500
Current qtr.	N/A	N/A	N/A	N/A
Next qtr.	N/A	N/A	N/A	N/A
Current year	N/A	N/A	N/A	N/A
Next year	11.70%	N/A	N/A	N/A
Next 5 years (per annum)	11.30%	N/A	N/A	N/A
Past 5 years (per annum)	8.19%	N/A	N/A	N/A